GRM5 and fragile X syndrome: In fact, recent studies have shown differential response of human iPS cell–derived neurons to mGluR5 NAMs compared with mouse neurons (36) and a lack of benefit of mGluR5 NAMs in human FXS iPS cell–derived cerebral organoid (37).